Brief: Targovax Gets Fast Track Designation For ONCOS-102 In Melanoma
June 22 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX RECEIVES FAST TRACK DESIGNATION FOR ONCOS-102 IN
MELANOMA
* US FDA GRANTS ONCOS-102 FAST TRACK DESIGNATION FOR
PD-1-REFRACTORY ADVANCED MELANOMA
Source text for Eikon: ID:nWkrXjtBF
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration